BIBilcare Limited
Other · · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on BI — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Profit growth: 1597.8% YoY
- • Promoter holding: 67.1%
- • MACD: bullish
- • Price vs EMA21: above
- • Trend strength (ADX): 27
- • 1-month return: +9.8%
Bull case
- • Profit growth: 1597.8% YoY
- • Promoter holding: 67.1%
- • MACD: bullish
- • Price vs EMA21: above
Bear case
- • Revenue growth: -3.3% YoY
- • ROE: -5.2%
- • Price vs SMA50: below
- • Supertrend: bearish
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: -3.3% YoY
- • ROE: -5.2%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹3.36). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.